Terms: = Bone cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Prognosis
23 results:
1. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH
Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953
[TBL] [Abstract] [Full Text] [Related]
2. Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
Kesby N; Mechera R; Fuchs T; Papachristos A; Gild M; Tsang V; Clifton-Bligh R; Robinson B; Sywak M; Sidhu S; Chou A; Gill AJ; Glover A
J Clin Endocrinol Metab; 2023 Sep; 108(10):2626-2634. PubMed ID: 36964913
[TBL] [Abstract] [Full Text] [Related]
3. Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid cancer: Efficacy, Safety, and Survival Predictors.
Liu Q; Kulkarni HR; Zhao T; Schuchardt C; Chen X; Zhu Z; Zhang J; Baum RP
Clin Nucl Med; 2023 Mar; 48(3):221-227. PubMed ID: 36723881
[TBL] [Abstract] [Full Text] [Related]
4. An Undetectable Postoperative Calcitonin Level Is Associated with Long-Term Disease-Free Survival in Medullary Thyroid Carcinoma: Results of a Retrospective Cohort Study.
Duval MADS; Ferreira CV; Marmitt L; Dora JM; Espíndola M; Benini AF; Camelier MV; Bulzico D; Andrade FA; Alves Júnior PA; Corbo R; Vaisman F; Zanella AB; Scheffel RS; Maia AL
Thyroid; 2023 Jan; 33(1):82-90. PubMed ID: 36222615
[No Abstract] [Full Text] [Related]
5. A novel Tmtc2-Ntrk3 fusion in undifferentiated high-grade pleomorphic sarcoma.
Bai C; Zhang L; Wang Y; You X; Ju Y; Sun T; Fan Z
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2933-2937. PubMed ID: 35933643
[TBL] [Abstract] [Full Text] [Related]
6.
Siozopoulou V; Marcq E; De Winne K; Norga K; Schmitz G; Duwel V; Delvenne P; Smits E; Pauwels P
Pathol Oncol Res; 2022; 28():1610423. PubMed ID: 35645621
[TBL] [Abstract] [Full Text] [Related]
7. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
[TBL] [Abstract] [Full Text] [Related]
8. Gene Fusions in Ocular Adnexal Tumors.
Milman T; Ida CM; Zhang PJL; Eagle RC
Am J Ophthalmol; 2021 Jan; 221():211-225. PubMed ID: 32800827
[TBL] [Abstract] [Full Text] [Related]
9. Real-World Efficacy and Safety of Cabozantinib and Vandetanib in Advanced Medullary Thyroid cancer.
Koehler VF; Adam P; Frank-Raue K; Raue F; Berg E; Hoster E; Allelein S; Schott M; Kroiss M; Spitzweg C
Thyroid; 2021 Mar; 31(3):459-469. PubMed ID: 32781914
[No Abstract] [Full Text] [Related]
10. bone Metastases in Medullary Thyroid Carcinoma: High Morbidity and Poor prognosis Associated With Osteolytic Morphology.
Vogel T; Wendler J; Frank-Raue K; Kreissl MC; Spitzweg C; Fassnacht M; Raue F; Kroiss M
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32072159
[TBL] [Abstract] [Full Text] [Related]
11. A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-ntrk1 gene fusion with durable clinical response to crizotinib: a case report.
Zhou N; Schäfer R; Li T; Fang M; Liu L
BMC Cancer; 2018 Aug; 18(1):842. PubMed ID: 30134855
[TBL] [Abstract] [Full Text] [Related]
12. Cabozantinib: Multi-kinase Inhibitor of MET, AXL, RET, and VEGFR2.
Grüllich C
Recent Results Cancer Res; 2018; 211():67-75. PubMed ID: 30069760
[TBL] [Abstract] [Full Text] [Related]
13. The curious case of a forehead metatypical basal cell carcinoma.
Florescu IP; Turcu EG; Carantino AM; Cocoşilă LC; Enache V; Neagu TP; Jecan CR
Rom J Morphol Embryol; 2018; 59(1):345-352. PubMed ID: 29940648
[TBL] [Abstract] [Full Text] [Related]
14. [Analysis of clinical characteristics of 187 patients with Marjolin's ulcers].
Liu Z; Zhou Y; Zhang P; Zhang M; Ren L; Zeng J; Zhou J; Liang P; Huang X
Zhonghua Shao Shang Za Zhi; 2016 May; 32(5):293-8. PubMed ID: 27188488
[TBL] [Abstract] [Full Text] [Related]
15. Mild to moderate increase of serum calcitonin levels only in presence of large medullary thyroid cancer deposits.
Pelizzo MR; Torresan F; Da Roit A; Merante Boschin I; Chondrogiannis S; Rampin L; Colletti PM; Vinjamury S; Perkins AJ; Rubello D
Rev Esp Med Nucl Imagen Mol; 2015; 34(6):378-82. PubMed ID: 26420439
[TBL] [Abstract] [Full Text] [Related]
16. Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer.
Kim HK; Bae WK; Choi YD; Shim HJ; Yoon JH; Kang HC
Thyroid; 2014 Mar; 24(3):599-603. PubMed ID: 23985043
[TBL] [Abstract] [Full Text] [Related]
17. Medullary thyroid carcinoma metastatic to skin.
Nashed C; Sakpal SV; Cherneykin S; Chamberlain RS
J Cutan Pathol; 2010 Dec; 37(12):1237-40. PubMed ID: 19615004
[TBL] [Abstract] [Full Text] [Related]
18. Medullary thyroid cancer: early detection and novel treatments.
Roman S; Mehta P; Sosa JA
Curr Opin Oncol; 2009 Jan; 21(1):5-10. PubMed ID: 19125012
[TBL] [Abstract] [Full Text] [Related]
19. MIBG for diagnosis and therapy of medullary thyroid carcinoma: is there still a role?
Castellani MR; Seregni E; Maccauro M; Chiesa C; Aliberti G; Orunesu E; Bombardieri E
Q J Nucl Med Mol Imaging; 2008 Dec; 52(4):430-40. PubMed ID: 19088696
[TBL] [Abstract] [Full Text] [Related]
20. Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma.
Haber M; Smith J; Bordow SB; Flemming C; Cohn SL; London WB; Marshall GM; Norris MD
J Clin Oncol; 2006 Apr; 24(10):1546-53. PubMed ID: 16575006
[TBL] [Abstract] [Full Text] [Related]
[Next]
